SGK
WST icon

Steigerwald Gordon & Koch’s West Pharmaceutical WST Stock Holding History

Steigerwald Gordon & Koch’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.33K Hold
26
– – ﹤0.01% 553
2026
Q1 		$6.52K Hold
26
– – ﹤0.01% 584
2025
Q4 		$7.15K Buy
+26
New +$7.11K ﹤0.01% 630

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Steigerwald Gordon & Koch's WST Position: Q2 2026 in Review

Steigerwald Gordon & Koch held its West Pharmaceutical (WST) position steady in Q2 2026 at 26 shares worth $9.33K. The position accounts for ﹤0.01% of the portfolio, ranked #553.

Steigerwald Gordon & Koch first reported a position in WST in Q4 2025 and has held it in 3 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Steigerwald Gordon & Koch held 26 shares of West Pharmaceutical worth $9.33K as of Q2 2026.
  • Steigerwald Gordon & Koch left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #553 holding.
  • Steigerwald Gordon & Koch first reported a position in West Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.